Literature DB >> 7699029

Isolation of the newly described species Mycobacterium celatum from AIDS patients.

E Tortoli1, C Piersimoni, D Bacosi, A Bartoloni, F Betti, L Bono, C Burrini, G De Sio, C Lacchini, A Mantella.   

Abstract

Mycobacterium celatum is a recently described species which, on the basis of conventional tests, may be misidentified as Mycobacterium xenopi or as belonging to the Mycobacterium avium complex. Only genomic sequencing or high-performance liquid chromatography of cell wall mycolic acids can presently allow a correct identification of this mycobacterium. Two cases of infection due to M. celatum, in AIDS patients, are described here. The quantitative susceptibility pattern of the isolates to a wide spectrum of drugs is also reported.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7699029      PMCID: PMC227895          DOI: 10.1128/jcm.33.1.137-140.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Phenacyl esters of fatty acids via crown ether catalysts for enhanced ultraviolet detection in liquid chromatography.

Authors:  H D Durst; M Milano; E J Kikta; S A Connelly; E Grushka
Journal:  Anal Chem       Date:  1975-09       Impact factor: 6.986

2.  CLASSIFICATION AND IDENTIFICATION OF MYCOBACTERIA. I. TESTS EMPLOYING TWEEN 80 AS SUBSTRATE.

Authors:  L G WAYNE; J R DOUBEK; R L RUSSELL
Journal:  Am Rev Respir Dis       Date:  1964-10

3.  Identification of mycobacteria by high-performance liquid chromatography.

Authors:  W R Butler; K C Jost; J O Kilburn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

4.  Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory.

Authors:  P Kirschner; B Springer; U Vogel; A Meier; A Wrede; M Kiekenbeck; F C Bange; E C Böttger
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 5.  Medical management of AIDS patients. Tuberculosis and nontuberculous mycobacterial disease.

Authors:  A E Pitchenik; D Fertel
Journal:  Med Clin North Am       Date:  1992-01       Impact factor: 5.456

6.  Simplified diagnostic susceptibility testing of mycobacteria against thiacetazone, hydroxylamine, p-nitrobenzoic acid and picric acid.

Authors:  A P Burnens; U Vurma-Rapp
Journal:  Res Microbiol       Date:  1989 Mar-Apr       Impact factor: 3.992

7.  The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).

Authors:  C R Horsburgh; R M Selik
Journal:  Am Rev Respir Dis       Date:  1989-01

8.  Disseminated infection due to Mycobacterium celatum in patient with AIDS.

Authors:  C Piersimoni; E Tortoli; G De Sio
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

9.  Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library.

Authors:  S E Glickman; J O Kilburn; W R Butler; L S Ramos
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Cross-reactivity of genetic probe for detection of Mycobacterium tuberculosis with newly described species Mycobacterium celatum.

Authors:  W R Butler; S P O'Connor; M A Yakrus; W M Gross
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

View more
  15 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Mycobacterium celatum infection in two HIV-infected patients treated prophylactically with rifabutin.

Authors:  Y Gholizadeh; A Varnerot; C Maslo; B Salauze; H Badaoui; V Vincent; A Buré-Rossier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

3.  Diversity of the 32-kilodalton protein gene may form a basis for species determination of potentially pathogenic mycobacterial species.

Authors:  H Soini; M K Viljanen
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Fatal pulmonary infection with Mycobacterium celatum in an apparently immunocompetent patient.

Authors:  I Bux-Gewehr; H P Hagen; S Rüsch-Gerdes; G E Feurle
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Application of the Sherlock Mycobacteria Identification System using high-performance liquid chromatography in a clinical laboratory.

Authors:  J A Kellogg; D A Bankert; G S Withers; W Sweimler; T E Kiehn; G E Pfyffer
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  False-positive results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis complex assay.

Authors:  A Somoskövi; J E Hotaling; M Fitzgerald; V Jonas; D Stasik; L M Parsons; M Salfinger
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

7.  Misidentification and diagnostic delay Caused by a false-positive amplified Mycobacterium tuberculosis direct test in an immunocompetent patient with a Mycobacterium celatum infection.

Authors:  J H Tjhie; A F van Belle; M Dessens-Kroon; D van Soolingen
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 8.  Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Mycobacterium conspicuum sp. nov., a new species isolated from patients with disseminated infections.

Authors:  B Springer; E Tortoli; I Richter; R Grünewald; S Rüsch-Gerdes; K Uschmann; F Suter; M D Collins; R M Kroppenstedt; E C Böttger
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

Review 10.  Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review.

Authors:  Claudio Piersimoni; Pier Giorgio Zitti; Domenico Nista; Stefano Bornigia
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.